NCT06443268Recruiting
Cerebrovascular Disease: Quality of Life (CODE: QoL)
Summary
The goal of this observational study is to learn about quality of life, stress and caregiver burden in patients with stroke and their caregivers. The main question is: • to discover the factors associated with quality of life and stress in patient-caregiver dyads. Participants will be asked to fill out questionnaires and agree to provide a hair sample (in order to measure stress hormones in hair) and consent to use of their routine clinical and laboratory data. Researchers will compare a group of participants without stroke to establish a comparable baseline.
Eligibility criteria
Control group: Inclusion criteria: • over 18 years old • No previous stroke OR previous stroke \>3 years ago • No significant disability (maximum mRS 1) • ambulatory patients at the University Hospital of Zurich (USZ), Dept. of Neurology • Patients' AND caregiver's ability to give informed consent • Patients' AND close relative's / caregiver's willingness to participate Exclusion criteria: • Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months Main Group: Inclusion criteria: • over 18 years old • Patients diagnosed with either transient ischemic attack, ischemic stroke or intracerebral hemorrhage and their caregivers • Caregiver of a patient as described above, age over 18 years • Hospitalized or ambulatory patients at the University Hospital of Zurich (USZ) included within 28 days from event. • Patients' AND caregiver's ability to give informed consent • Patients' AND caregiver's willingness to participate Exclusion criteria: • Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Countries
- Switzerland
- Sponsor
- University of Zurich(Other)
- Protocol no.
- 2023-00224
- Conditions
- Quality of Life, Stroke, Acute, Sexual Behavior, Stress, Cortisol Excess, Incontinence, Urinary, Caregiver Burden, Transient Ischemic Attack, Intracerebral Hemorrhage, Cerebrovascular Disorders
- Interventions
- Diagnostic test
Treatments studied
- questionnaire, hair samples, blood samples, clinical exam
Locations · 1
- Zurich, SwitzerlandDepartment of Neurology, University Hospital ZurichRecruiting at this site
In total, worldwide, the only site listed in the registry is recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: June 5, 2024).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
Other identifiers
- 2023 · NIH grant
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.